ASCLERA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Asclera, and what generic alternatives are available?
Asclera is a drug marketed by Chemisch Fbrk Krsslr and is included in one NDA.
The generic ingredient in ASCLERA is polidocanol. Two suppliers are listed for this compound. Additional details are available on the polidocanol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ASCLERA?
- What are the global sales for ASCLERA?
- What is Average Wholesale Price for ASCLERA?
Summary for ASCLERA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 74 |
| Clinical Trials: | 3 |
| Patent Applications: | 2,638 |
| What excipients (inactive ingredients) are in ASCLERA? | ASCLERA excipients list |
| DailyMed Link: | ASCLERA at DailyMed |
Recent Clinical Trials for ASCLERA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Massachusetts General Hospital | Phase 1 |
| Johns Hopkins University | Phase 1 |
| UPECLIN HC FM Botucatu Unesp | Phase 4 |
Pharmacology for ASCLERA
| Drug Class | Sclerosing Agent |
| Mechanism of Action | Sclerosing Activity |
| Physiological Effect | Vascular Sclerosing Activity |
US Patents and Regulatory Information for ASCLERA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemisch Fbrk Krsslr | ASCLERA | polidocanol | SOLUTION;INTRAVENOUS | 021201-001 | Mar 30, 2010 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chemisch Fbrk Krsslr | ASCLERA | polidocanol | SOLUTION;INTRAVENOUS | 021201-002 | Mar 30, 2010 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
